WO2008157365A3 - Vinylazacycloalkanes for treating neuropathic pain - Google Patents
Vinylazacycloalkanes for treating neuropathic pain Download PDFInfo
- Publication number
- WO2008157365A3 WO2008157365A3 PCT/US2008/066939 US2008066939W WO2008157365A3 WO 2008157365 A3 WO2008157365 A3 WO 2008157365A3 US 2008066939 W US2008066939 W US 2008066939W WO 2008157365 A3 WO2008157365 A3 WO 2008157365A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- neuropathic pain
- vinylazacycloalkanes
- treating neuropathic
- treating
- invention includes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention includes methods and compositions for treating or preventing neuropathic pain. The present invention includes compounds for use in treating or preventing neuropathic pain. The present invention includes the use of compounds in the manufacture of a medicament for the treatment or prevention of neuropathic pain.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94429407P | 2007-06-15 | 2007-06-15 | |
US60/944,294 | 2007-06-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008157365A2 WO2008157365A2 (en) | 2008-12-24 |
WO2008157365A3 true WO2008157365A3 (en) | 2009-04-16 |
Family
ID=39711086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/066939 WO2008157365A2 (en) | 2007-06-15 | 2008-06-13 | Vinylazacycloalkanes for treating neuropathic pain |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008157365A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9145396B2 (en) | 2008-12-01 | 2015-09-29 | Targacept, Inc. | Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine |
US8604191B2 (en) * | 2008-12-01 | 2013-12-10 | Targacept, Inc. | Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3YLVINYL)pyrimidine |
EP2544690A4 (en) * | 2010-03-11 | 2013-07-10 | Targacept Inc | Arylvinylazacycloalkane compounds for constipation |
ES2893126T3 (en) * | 2016-04-07 | 2022-02-08 | Oyster Point Pharma Inc | Treatment methods for eye conditions |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004078752A1 (en) * | 2003-03-05 | 2004-09-16 | Targacept Inc. | Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
WO2007099828A1 (en) * | 2006-02-23 | 2007-09-07 | Shionogi & Co., Ltd. | Nirogenous heterocyclic derivatives substituted with cyclic groups |
-
2008
- 2008-06-13 WO PCT/US2008/066939 patent/WO2008157365A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004078752A1 (en) * | 2003-03-05 | 2004-09-16 | Targacept Inc. | Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
WO2007099828A1 (en) * | 2006-02-23 | 2007-09-07 | Shionogi & Co., Ltd. | Nirogenous heterocyclic derivatives substituted with cyclic groups |
EP1988077A1 (en) * | 2006-02-23 | 2008-11-05 | Shionogi & Co., Ltd. | Nirogenous heterocyclic derivatives substituted with cyclic groups |
Non-Patent Citations (1)
Title |
---|
KESINGLAND A C ET AL: "Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain", PAIN, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 86, no. 1-2, 1 May 2000 (2000-05-01), pages 113 - 118, XP002217587, ISSN: 0304-3959 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008157365A2 (en) | 2008-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL207713A0 (en) | Formulation and method for the prevention and treatment of bone metastases or other bone diseases | |
IL210810A0 (en) | Compositions for the treatment of pain and/or inflamtion | |
WO2006024018A3 (en) | Compositions for treating nociceptive pain | |
ZA200907575B (en) | C3b antobodies and methods for the prevention and treatment of complement associated disorders | |
WO2007104053A3 (en) | 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders | |
WO2008036238A3 (en) | Use of lxr modulators for the prevention and treatment of skin aging | |
IL213489A0 (en) | Compositions and methods for the treatment of the prevention of e. coli infections and for the eradication or reduction of e. coli surfaces | |
EP2229459A4 (en) | Methods and compositions for prevention or treatment of rsv infection | |
WO2008124660A3 (en) | Methods and compositions for the treatment of cancer | |
WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
WO2008089310A3 (en) | Delta 5 desaturase inhibitors for the treatment of obesity | |
GB0610350D0 (en) | prevention and/or treatment of neuodegenerative disorders | |
IL187565A0 (en) | Compositions and methods for the treatment or prevention of chemoresistant neoplasia | |
EP2061510A4 (en) | Treatment and/or prevention of non-infectious medical conditions using antibody-containing compositions | |
WO2007146335A3 (en) | Compounds and compositions for treatment of cancer | |
HUE044621T2 (en) | Compounds and methods for the prevention or treatment of restenosis | |
WO2007112121A3 (en) | Tetracycline compounds and methods of treatment | |
WO2008016640A3 (en) | Use of poloxamer for the prevention and/or treatment of heart failure | |
WO2009011910A3 (en) | Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment | |
WO2008155390A3 (en) | Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases. | |
WO2008157365A3 (en) | Vinylazacycloalkanes for treating neuropathic pain | |
WO2011029639A3 (en) | Compounds and methods for treating neoplasia | |
WO2010042212A3 (en) | Methods for treating or preventing pain using spicamycin derivatives | |
WO2010065085A3 (en) | Methods and compositions for treating or preventing pruritis | |
WO2010150098A3 (en) | Use of quingolide in the treatment of endometriosis, pain and cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08771037 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08771037 Country of ref document: EP Kind code of ref document: A2 |